https://adisinsight.springer.com/trials/700047388?error=cookies_not_supported&code=3bad06d0-a23b-425f-8ce4-307bbcdf4eb2
RNOP-09: Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in...
Glioblastomas represent 40% of all tumors of the central nervous system (CNS) and are among the most lethal tumors. Temozolomide (TMZ) combined with